Innoviva

Innoviva Dividend

The Dividend of Innoviva (INVA) as of Nov 22, 2026 is 0.75 USD. In the previous year, Dividend was 0.50 USD — a change of 50.00% (higher).

Dividend

0.75USD

YoY

50.00%

Dividend yield

4.07 %

Last updated:

How much dividend does Innoviva 2026 pay?

According to the latest status from November 2026, Innoviva paid a total of 0.75 USD per share in dividends within the last 12 months. With the current Innoviva price of 18.41 USD, this corresponds to a dividend yield of - %. A dividend is paid times per year.

Innoviva currently offers a dividend yield of about 4.07%.

Historical Innoviva Dividends

Historical Innoviva Dividends
PaydateDividend
0.25USD
0.25USD
0.25USD
0.25USD
0.25USD

The Innoviva Dividend history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Date
Dividend
Jan 1, 2023
0.00 USD
Jan 1, 2024
0.00 USD
Jan 1, 2025
0.00 USD
Jan 1, 2026 (e)
1.00 USD
Jan 1, 2027 (e)
1.00 USD
Jan 1, 2028 (e)
1.00 USD
Jan 1, 2029 (e)
1.00 USD
Jan 1, 2030 (e)
1.00 USD
The Innoviva Dividend history
YEARDividendYoY
est1.00USD0.00%
est1.00USD0.00%
est1.00USD0.00%
est1.00USD0.00%
est1.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD-100.00%
0.75USD+50.00%
0.50USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—
0.00USD—

Is the Innoviva Dividend Safe?

Innoviva has been increasing the dividend for 1 years.

Analysts expect a Dividend Cut of -100.00% for the current fiscal year.

Innoviva dividend payout ratio

In 2025, Innoviva had a payout ratio of 0.00%. The payout ratio indicates the percentage of the company's profits that Innoviva distributes as dividends.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2021
0.00 %
Jan 1, 2022
0.00 %
Jan 1, 2023
0.00 %
Jan 1, 2024
0.00 %
Jan 1, 2025
0.00 %
Jan 1, 2026 (e)
127.39 %
Jan 1, 2027 (e)
48.54 %
Jan 1, 2028 (e)
49.10 %

Dividend Details

Understanding Innoviva's Dividend Distributions

Innoviva’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Innoviva's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Innoviva's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Innoviva’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Innoviva Stock analysis

What does Innoviva do? Innoviva Inc - An innovative story Innoviva Inc is a US-based company specializing in the development and marketing of therapy and diagnostic products for respiratory diseases. The company was founded in 1996 under the name Theravance Inc and was renamed Innoviva Inc in 2016. The story of Innoviva Inc began with the goal of developing innovative therapies for chronic respiratory diseases. Over the years, the company expanded and diversified its product portfolio. Today, Innoviva Inc is a leading provider of products for the treatment of asthma and chronic obstructive pulmonary disease (COPD). Business model of Innoviva Inc The business model of Innoviva Inc is based on the development of products for the treatment of respiratory diseases and collaboration with other pharmaceutical and biotech companies. The company licenses its products to partner companies, which distribute them in the market. This way, Innoviva Inc generates revenue from licensing fees and milestone payments. Divisions of Innoviva Inc Innoviva Inc is divided into three divisions: development, licensing, and financing. The development division is responsible for researching and developing new therapy and diagnostic products. The company works closely with other pharmaceutical and biotech companies in this regard. The licensing division is responsible for licensing products to partner companies. This includes negotiating license agreements and conducting clinical trials. The financing division of Innoviva Inc is responsible for raising external capital. This includes issuing bonds and seeking investment. Products of Innoviva Inc Innoviva Inc has a wide range of therapy and diagnostic products for respiratory diseases. These include: - RELVAR®/BREO® (Fluticasone furoate/Vilanterol) for the treatment of COPD and asthma - ANORO® (Umeclidinium bromide/Vilanterol) for the treatment of COPD - TRELEGY® (Fluticasone furoate/Umeclidinium bromide/Vilanterol) for the treatment of COPD These products have been developed by Innoviva Inc and are licensed to partner companies for distribution. Innoviva Inc is an innovative company specializing in the development and marketing of products for the treatment of respiratory diseases. The business model is based on the development of products and licensing them to partner companies. Innoviva Inc has a wide range of therapy and diagnostic products for respiratory diseases. Innoviva is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Innoviva stock

Over the past 12 months, Innoviva paid a dividend of 0.75 USD . This corresponds to a dividend yield of about 4.07 %. For the coming 12 months, Innoviva is expected to pay a dividend of 1.00 USD.

The current dividend yield of Innoviva is 4.07 %.

Innoviva pays a dividend, distributed in the months of November, March, June, September.

Innoviva paid dividends every year for the past 0 years.

For the upcoming 12 months, dividends amounting to 1.00 USD are expected. This corresponds to a dividend yield of 5.43 %.

Innoviva is assigned to the 'Health' sector.

To receive the latest dividend of Innoviva from 9/30/2015 amounting to 0.25 USD, you needed to have the stock in your portfolio before the ex-date on 9/8/2015.

The last dividend was paid out on 9/30/2015.

In the year 2015, Innoviva distributed 0.75 USD as dividends.

The dividends of Innoviva are distributed in USD.

Dividend calendar 2026

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

All Key Metrics — Innoviva